Earnings
Oxford Immunotec, a global, high-growth diagnostics company, today announced fourth quarter and full year 2018 financial results.
Board Authorizes $6 Billion for Share Repurchases
Significant Progress with Novel Diabetic Eye Disease Portfolio
Neos Therapeutics, Inc. today announced that it will report its fourth quarter and year-end 2018 financial results prior to the opening of U.S. financial markets on Thursday, March 14, 2019.
Full year revenues from product sales were up over 51% on 2017 to €134.3 million, reflecting strong growth in both the USA and Europe. Including deferred license income, total revenues were €135.1 million (US$159.7 million) – an increase of almost 51% on 2017
Annual General Meeting to take place on 18 April 2019 in Basel
BATM Advanced Communications Limited (LSE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces its final results for the year ended 31 December 2018.
Continued good sales growth and strong operating profit
Reports Neurology Franchise Annual Net Sales of $110.3 million, at the High End of Guidance Range
Coming off its record-breaking initial public offering (IPO) in December, where it raised $604.3 million, Moderna released its fourth-quarter financials, outlining an ambitious company buzzing with activity.
PRESS RELEASES